SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-20-000031
Filing Date
2020-05-15
Accepted
2020-05-15 16:28:01
Documents
90
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20200331.htm   iXBRL 10-Q 1634073
2 EX-31.1 supn-20200331x10qxex311.htm EX-31.1 11433
3 EX-31.2 supn-20200331x10qxex312.htm EX-31.2 12621
4 EX-32.1 supn-20200331x10qxex321.htm EX-32.1 6128
5 EX-32.2 supn-20200331x10qxex322.htm EX-32.2 6154
11 supn-20200331_g1.jpg GRAPHIC 72236
  Complete submission text file 0001356576-20-000031.txt   7356978

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20200331.xsd EX-101.SCH 49104
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20200331_cal.xml EX-101.CAL 96557
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20200331_def.xml EX-101.DEF 224289
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20200331_lab.xml EX-101.LAB 575847
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20200331_pre.xml EX-101.PRE 375760
71 EXTRACTED XBRL INSTANCE DOCUMENT supn-20200331_htm.xml XML 1277610
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 20885805
SIC: 2834 Pharmaceutical Preparations